Inhibition by endothelial cells of platelet aggregating activity of thrombin--role of thrombomodulin. 1988

M Murata, and Y Ikeda, and Y Araki, and H Murakami, and K Sato, and M Yamamoto, and K Watanabe, and Y Ando, and T Igawa, and I Maruyama
Department of Haematology, Keio University, Tokyo, Japan.

Cultured human umbilical vein endothelial cells inhibited the platelet aggregating activity of thrombin in the absence of plasma. Using a new method in which thrombin-induced platelet aggregation was measured in the presence of endothelial cells, we showed that aspirin-treated endothelial cells inhibited platelet aggregating activity of thrombin in an incubation time- and cell number-dependent manner. This inhibitory effect of endothelial cells was partially blocked by the pretreatment of endothelial cells with monoclonal anti-thrombomodulin IgG (anti-TMIgG). It is suggested that (1) endothelial cells play a role in the clearance of thrombin by binding and inactivating this enzyme and that (2) thrombomodulin on endothelial cells, apart from its role for protein C activation, may be involved in this endothelial function.

UI MeSH Term Description Entries
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic
D013917 Thrombin An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN. Thrombase,Thrombin JMI,Thrombin-JMI,Thrombinar,Thrombostat,alpha-Thrombin,beta,gamma-Thrombin,beta-Thrombin,gamma-Thrombin,JMI, Thrombin
D018179 Receptors, Thrombin A family of proteinase-activated receptors that are specific for THROMBIN. They are found primarily on PLATELETS and on ENDOTHELIAL CELLS. Activation of thrombin receptors occurs through the proteolytic action of THROMBIN, which cleaves the N-terminal peptide from the receptor to reveal a new N-terminal peptide that is a cryptic ligand for the receptor. The receptors signal through HETEROTRIMERIC GTP-BINDING PROTEINS. Small synthetic peptides that contain the unmasked N-terminal peptide sequence can also activate the receptor in the absence of proteolytic activity. Thrombin Receptors,TRAP Peptide,Thrombin Receptor,Thrombin Receptor Activating Peptide Ligand,Thrombin Receptor Activating Peptides,Thrombin Receptor Activator Peptide,Peptide, TRAP,Receptor, Thrombin

Related Publications

M Murata, and Y Ikeda, and Y Araki, and H Murakami, and K Sato, and M Yamamoto, and K Watanabe, and Y Ando, and T Igawa, and I Maruyama
January 2008, Endothelium : journal of endothelial cell research,
M Murata, and Y Ikeda, and Y Araki, and H Murakami, and K Sato, and M Yamamoto, and K Watanabe, and Y Ando, and T Igawa, and I Maruyama
February 1990, Thrombosis research,
M Murata, and Y Ikeda, and Y Araki, and H Murakami, and K Sato, and M Yamamoto, and K Watanabe, and Y Ando, and T Igawa, and I Maruyama
April 1995, Protein science : a publication of the Protein Society,
M Murata, and Y Ikeda, and Y Araki, and H Murakami, and K Sato, and M Yamamoto, and K Watanabe, and Y Ando, and T Igawa, and I Maruyama
January 2014, Xenotransplantation,
M Murata, and Y Ikeda, and Y Araki, and H Murakami, and K Sato, and M Yamamoto, and K Watanabe, and Y Ando, and T Igawa, and I Maruyama
October 1993, Stroke,
M Murata, and Y Ikeda, and Y Araki, and H Murakami, and K Sato, and M Yamamoto, and K Watanabe, and Y Ando, and T Igawa, and I Maruyama
January 1985, Invasion & metastasis,
M Murata, and Y Ikeda, and Y Araki, and H Murakami, and K Sato, and M Yamamoto, and K Watanabe, and Y Ando, and T Igawa, and I Maruyama
March 1994, Biochemical and biophysical research communications,
M Murata, and Y Ikeda, and Y Araki, and H Murakami, and K Sato, and M Yamamoto, and K Watanabe, and Y Ando, and T Igawa, and I Maruyama
April 1987, Cancer research,
M Murata, and Y Ikeda, and Y Araki, and H Murakami, and K Sato, and M Yamamoto, and K Watanabe, and Y Ando, and T Igawa, and I Maruyama
January 1998, Biochemistry,
M Murata, and Y Ikeda, and Y Araki, and H Murakami, and K Sato, and M Yamamoto, and K Watanabe, and Y Ando, and T Igawa, and I Maruyama
January 1992, Seminars in thrombosis and hemostasis,
Copied contents to your clipboard!